Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies

Details for Australian Patent Application No. 2001255488 (hide)

Owner Allergan, Inc. The Trustees of the University of Pennsylvania

Inventors Chandraratna, Roshantha A; Pacifici, Maurizio

Agent Davies Collison Cave

Pub. Number AU-B-2001255488

PCT Pub. Number WO01/80894

Priority 09/552,823 20.04.00 US

Filing date 19 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 27 July 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/19 (2006.01)

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

Event Publications

27 July 2006 Assignment before Grant

  Allergan, Inc. The application has been assigned to Allergan, Inc.; The Trustees of the University of Pennsylvania

27 July 2006 Application Accepted

  Published as AU-B-2001255488

23 November 2006 Standard Patent Sealed

1 February 2007 Licence Registered

  Allergan, Inc.; The Trustees of the University of Pennsylvania ( Vitae Pharmaceuticals, Inc. )

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001255489

2001255487